Maser E, Netter K J
Department of Pharmacology and Toxicology, School of Medicine, University of Marburg, Lahn, Federal Republic of Germany.
Biochem Pharmacol. 1991 Jun 1;41(11):1595-9. doi: 10.1016/0006-2952(91)90159-3.
Mouse liver cytosol catalyses the reduction of metyrapone to the corresponding alcohol metabolite metyrapol. The enzyme involved was characterized as a NADPH-dependent carbonyl reductase which is strongly inhibited by the plant flavonoid quercitrin but which shows no sensitivity to phenobarbital. Thus, by inhibitor subdivision of carbonyl reductases the metyrapone reductase in mouse liver cytosol has to be classified as a ketone reductase rather than an aldehyde reductase, as it was shown previously for the analogous enzyme in mouse liver microsomes based on the same pattern of inhibitor classification. Moreover, immunological comparison of the metyrapone reductases from the two subcellular fractions reveal no common antigenic determinants indicating the structural difference between these enzymes. In conclusion, metyrapone undergoes reductive biotransformation mediated by two clearly distinct carbonyl reductases located in different subcellular compartments of mouse liver cells. Considering the convenient and sensitive HPLC-method for direct metyrapol determination, metyrapone may serve as a useful tool in the investigation of these enzymes, although their physiological roles remain to be determined.
小鼠肝细胞溶胶可催化美替拉酮还原为相应的醇代谢产物甲吡唑。所涉及的酶被鉴定为一种依赖烟酰胺腺嘌呤二核苷酸磷酸(NADPH)的羰基还原酶,它受到植物类黄酮槲皮苷的强烈抑制,但对苯巴比妥不敏感。因此,通过羰基还原酶的抑制剂分类,小鼠肝细胞溶胶中的美替拉酮还原酶必须归类为酮还原酶而非醛还原酶,正如之前基于相同抑制剂分类模式对小鼠肝微粒体中类似酶的研究所示。此外,对来自这两个亚细胞组分的美替拉酮还原酶进行免疫比较,未发现共同的抗原决定簇,这表明这些酶在结构上存在差异。总之,美替拉酮经历由位于小鼠肝细胞不同亚细胞区室的两种明显不同的羰基还原酶介导的还原性生物转化。考虑到用于直接测定甲吡唑的便捷且灵敏的高效液相色谱法,美替拉酮可能是研究这些酶的有用工具,尽管它们的生理作用仍有待确定。